Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Antithrombotic/antiallergic agents from Terumo

Nov. 22, 1996

Genetics Institute's factor IX scheduled for review

Nov. 21, 1996

Clinical trial compares therapeutic potential of heparin and hirudin in coronary thrombosis

Nov. 21, 1996

Hirudin-based thrombin inhibitors reported by Canadian investigators

Nov. 19, 1996

CAPRIE study demonstrates clopidogrel more effective than aspirin

Nov. 15, 1996

Preclinical and clinical pharmacological profile of efegatran

Nov. 15, 1996

Ciba-Geigy describes trypsin/thrombin inhibitors

Nov. 15, 1996

FDA clears new heart attack drug

Nov. 8, 1996

Japanese researchers report potential fibrinolytic agent

Nov. 8, 1996

Novel PAI-1 inhibitor discovered by Xenova

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 11, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...